O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY
| Autor: | Wedemeyer, H., Yurdaydin, C., Ernst, S., Caruntu, F.A., Curescu, M.G., Yalcin, K., Akarca, U.S., Gürel, S., Zeuzem, S., Erhardt, A., Lüth, S., Papatheodoridis, G.V., Keskin, O., Port, K., Radu, M., Celen, M.K., Ildeman, R., Stift, J., Heidrich, B., Mederacke, I., Hardtke, S., Koch, A., Dienes, H.P., Manns, M.P. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2014 60(1) Supplement:S2-S3 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect